Wall Street Zen Upgrades MKS (NASDAQ:MKSI) to Strong-Buy

MKS (NASDAQ:MKSI) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Several other equities research analysts have also recently weighed in on the stock. Wells Fargo & Company raised their price objective on shares of MKS from $300.00 to $325.00 and gave the company an “equal weight” rating in a research report on Friday. BMO Capital Markets started coverage on shares of MKS in a research report on Tuesday, June 30th. They set an “outperform” rating and a $453.00 target price on the stock. JPMorgan Chase & Co. increased their price target on shares of MKS from $365.00 to $380.00 and gave the company an “overweight” rating in a research note on Friday. Cantor Fitzgerald restated an “overweight” rating and issued a $600.00 price objective on shares of MKS in a research report on Monday, August 3rd. Finally, Citigroup upped their price objective on MKS from $425.00 to $430.00 and gave the stock a “buy” rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

MKS Price Performance

MKS stock opened at $304.99 on Friday. The business’s fifty day moving average is $347.80 and its two-hundred day moving average is $289.71. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14. The firm has a market cap of $20.60 billion, a P/E ratio of 48.64, a P/E/G ratio of 0.80 and a beta of 1.98. MKS has a 52 week low of $97.30 and a 52 week high of $447.62.

MKS (NASDAQ:MKSI) last announced its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.39. MKS had a return on equity of 24.72% and a net margin of 10.15%.The company had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same period last year, the company posted $1.77 earnings per share. The firm’s quarterly revenue was up 28.3% compared to the same quarter last year. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities research analysts forecast that MKS will post 12.05 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Ramakumar Mayampurath sold 8,810 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $315.48, for a total value of $2,779,378.80. Following the completion of the sale, the chief financial officer owned 1 shares in the company, valued at approximately $315.48. This represents a 99.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP David Philip Henry sold 2,500 shares of the stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total value of $826,250.00. Following the completion of the transaction, the executive vice president directly owned 16,341 shares in the company, valued at $5,400,700.50. The trade was a 13.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 50,051 shares of company stock worth $16,184,527 over the last 90 days. 0.57% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On MKS

Several institutional investors have recently modified their holdings of MKSI. First National Bank of Omaha bought a new stake in shares of MKS in the 2nd quarter valued at about $4,735,000. K2 Principal Fund L.P. bought a new position in MKS during the 2nd quarter worth approximately $1,557,000. Meeder Advisory Services Inc. bought a new position in MKS during the 2nd quarter worth approximately $2,288,000. Citizens Financial Group Inc. RI acquired a new position in MKS during the second quarter valued at approximately $546,000. Finally, Focused Alpha LLC acquired a new position in MKS during the second quarter valued at approximately $353,000. 99.79% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Analysts raise price targets: Citigroup lifted its target from $425 to $430 and initiated a Buy rating; JPMorgan raised its target from $365 to $380 and maintained an Overweight rating. Needham also increased its target to $390 from $360 and retained a Buy rating. Citigroup analyst action JPMorgan analyst action Needham analyst action
• Positive Sentiment: Q2 earnings beat expectations: MKS reported adjusted earnings of $3.30 per share, above the approximately $2.94 consensus estimate and up from $1.77 a year earlier. Revenue reached $1.25 billion, exceeding forecasts of roughly $1.20 billion and rising 28.3% year over year. Management’s third-quarter guidance also supports an upbeat near-term view. MKS Q2 earnings beat estimates
• Positive Sentiment: AI demand improves visibility: MKS is ramping semiconductor and advanced-packaging capacity to meet AI-related demand, potentially supporting growth visibility into 2027 and strengthening the long-term investment case. MKSI Q2 earnings call highlights
• Neutral Sentiment: Brokerages collectively assign MKS a “Moderate Buy” recommendation, while Wells Fargo raised its target from $300 to $325 but retained an Equal Weight rating, indicating a more measured view. MKS consensus recommendation Wells Fargo analyst action
• Negative Sentiment: The AI-related capacity expansion is creating near-term margin pressure, a risk that could limit immediate earnings leverage even as demand prospects improve.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.